Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Brady

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Haematologica|October 29, 2017
GA101 P329GLALA, a variant of obinutuzumab with abolished ADCC, ADCP and CDC function but retained cell death induction, is as efficient as rituximab in B-cell depletion and antitumor activitySylvia Herter, Frank Herting, Gunter Muth, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2012
Kappa agonist CovX-BodiesLee R Roberts, Kevin Brady, Amy Brown, et al.
Therapeutic Advances in Medical Oncology|March 5, 2026
Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitorsRobert Hsu, Karen Resnick, Peter Zang, et al.
Cell Reports|January 4, 2018
Brain Shuttle Antibody for Alzheimer's Disease with Attenuated Peripheral Effector Function due to an Inverted Binding ModeFelix Weber, Bernd Bohrmann, Jens Niewoehner, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapyHelen Lavender, Kevin Brady, Frances Burden, et al.
Diabetes Research and Clinical Practice|March 21, 2025
The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetesTadej Battelino, Nebojsa Lalic, Sufyan Hussain, et al.
Journal of Investigative Medicine High Impact Case Reports|March 22, 2021
Incidental Finding of a Large Right Atrial Thrombus in a Patient With Cerebral LymphomaAyman R Fath, Abdullah S Eldaly, Amro Aglan, et al.
Mabs|October 12, 2023
Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humansHans Peter Grimm, Vanessa Schumacher, Martin Schäfer, et al.
Journal of Autoimmunity|November 18, 2018
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune diseaseLaurence B Peterson, Charles J M Bell, Sarah K Howlett, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 27, 2017
From the Cover: The Minipig is a Suitable Non-Rodent Model in the Safety Assessment of Single Stranded OligonucleotidesAnnamaria Braendli-Baiocco, Matthias Festag, Kamille Dumong Erichsen, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Haematologica|October 29, 2017
GA101 P329GLALA, a variant of obinutuzumab with abolished ADCC, ADCP and CDC function but retained cell death induction, is as efficient as rituximab in B-cell depletion and antitumor activitySylvia Herter, Frank Herting, Gunter Muth, et al.
Bioorganic & Medicinal Chemistry Letters|May 16, 2012
Kappa agonist CovX-BodiesLee R Roberts, Kevin Brady, Amy Brown, et al.
Therapeutic Advances in Medical Oncology|March 5, 2026
Impact of race/ethnicity and the presence of immune-related adverse events on outcomes for non-small cell lung cancer patients treated with immune checkpoint inhibitorsRobert Hsu, Karen Resnick, Peter Zang, et al.
Cell Reports|January 4, 2018
Brain Shuttle Antibody for Alzheimer's Disease with Attenuated Peripheral Effector Function due to an Inverted Binding ModeFelix Weber, Bernd Bohrmann, Jens Niewoehner, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2011
In vitro characterization of the activity of PF-05095808, a novel biological agent for hepatitis C virus therapyHelen Lavender, Kevin Brady, Frances Burden, et al.
Diabetes Research and Clinical Practice|March 21, 2025
The use of continuous glucose monitoring in people living with obesity, intermediate hyperglycemia or type 2 diabetesTadej Battelino, Nebojsa Lalic, Sufyan Hussain, et al.
Journal of Investigative Medicine High Impact Case Reports|March 22, 2021
Incidental Finding of a Large Right Atrial Thrombus in a Patient With Cerebral LymphomaAyman R Fath, Abdullah S Eldaly, Amro Aglan, et al.
Mabs|October 12, 2023
Delivery of the Brainshuttle™ amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humansHans Peter Grimm, Vanessa Schumacher, Martin Schäfer, et al.
Journal of Autoimmunity|November 18, 2018
A long-lived IL-2 mutein that selectively activates and expands regulatory T cells as a therapy for autoimmune diseaseLaurence B Peterson, Charles J M Bell, Sarah K Howlett, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|January 27, 2017
From the Cover: The Minipig is a Suitable Non-Rodent Model in the Safety Assessment of Single Stranded OligonucleotidesAnnamaria Braendli-Baiocco, Matthias Festag, Kamille Dumong Erichsen, et al.
Pageof 5